These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1169709)

  • 21. [Histocompatibility antigens in multiple sclerosis patients].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM; Kut'ina RM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):7-10. PubMed ID: 7234266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA haplotypes in families with high frequency of multiple sclerosis.
    Olsson JE; Möller E; Link H
    Arch Neurol; 1976 Dec; 33(12):808-12. PubMed ID: 999543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA antigens in black American patients with multiple sclerosis.
    Dupont B; Lisak RP; Jersild C; Hansen JA; Silberberg DH; Whitsett C; Zweiman B; Ciongoli K
    Transplant Proc; 1977 Mar; 9(1 Suppl 1):181-5. PubMed ID: 67674
    [No Abstract]   [Full Text] [Related]  

  • 24. HLA antigens in multiple sclerosis.
    Thorsby E; Helgesen A; Solheim BG; Vandvik B
    J Neurol Sci; 1977 Jun; 32(2):187-93. PubMed ID: 301557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multiple sclerosis and psoriasis].
    Cendrowski W
    Wiad Lek; 1989 May; 42(9):575-8. PubMed ID: 2629326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple sclerosis immunogenetics: a) associations between HL-A antigens and high measles antibody levels. b) existence of common MLR/immune response determinants in MS patients.
    Cazzullo CL; Smeraldi E
    Boll Ist Sieroter Milan; 1974; 53(5):615-24. PubMed ID: 4282585
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunogenetics of multiple sclerosis: relationship between histocompatibility antigens and susceptibility to the disease].
    Smeraldi E
    Boll Ist Sieroter Milan; 1972; 51(3):220-3. PubMed ID: 4653137
    [No Abstract]   [Full Text] [Related]  

  • 28. [Multiple sclerosis and the histocompatibility system].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):167-71. PubMed ID: 6176089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histocompatibility antigens and multiple sclerosis.
    Lancet; 1976 Dec; 2(7998):1286-7. PubMed ID: 63754
    [No Abstract]   [Full Text] [Related]  

  • 30. [Major histocompatibility system in multiple sclerosis].
    Oger J; Sabouraud O; Fauchet R; Genetet N; Menault F; Genetet B
    Rev Neurol (Paris); 1976 Feb; 132(2):89-97. PubMed ID: 973072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe.
    Ballerini C; Guerini FR; Rombolà G; Rosati E; Massacesi L; Ferrante P; Caputo D; Talamanca LF; Naldi P; Liguori M; Alizadeh M; Momigliano-Richiardi P; D'Alfonso S
    J Neuroimmunol; 2004 May; 150(1-2):178-85. PubMed ID: 15081263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood group specific components and systems in multiple sclerosis. Preliminary report.
    Wender M; Przybylski Z; Chmielewska U
    Riv Patol Nerv Ment; 1978; 99(1):14-21. PubMed ID: 752894
    [No Abstract]   [Full Text] [Related]  

  • 33. [Histocompatibility patterns in multiple sclerosis. Findings of an epidemiological study (author's transl)].
    Poser S; Ritter G; Bauer HJ; Kuwert EK; Höher PG; Grosse-Wilde H; Hierholzer E
    Nervenarzt; 1981 Jun; 52(6):326-8. PubMed ID: 6973699
    [No Abstract]   [Full Text] [Related]  

  • 34. Histocompatibility determinants in multiple sclerosis.
    Jersild C; Dupont B; Fog T; Platz PJ; Svejgaard A
    Transplant Rev; 1975; 22():148-63. PubMed ID: 46643
    [No Abstract]   [Full Text] [Related]  

  • 35. The major histocompatibility system, HLA, and multiple sclerosis.
    Jersild C
    Acta Neurol Scand Suppl; 1977; 63():17-21. PubMed ID: 66848
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased susceptibility to endocrine opthalmopathy in HLA CW3 positive thyrotoxicosis patients [proceedings].
    Ludwig H; Schernthaner G; Mayr WR; Mehdi SQ
    Diabete Metab; 1976 Sep; 2(3):163. PubMed ID: 1010142
    [No Abstract]   [Full Text] [Related]  

  • 37. Hla antigens and haplotypes in 200 patients with aplastic anemia.
    Albert E; Thomas ED; Nisperos B; Storb R; Camitta BM; Parkman R
    Transplantation; 1976 Nov; 22(5):528-31. PubMed ID: 996929
    [No Abstract]   [Full Text] [Related]  

  • 38. Rapid HLA-D matching method using PHA blasts as responding cells.
    Charmot D; Comoy A; Mawas C; Sasportes M
    Transplant Proc; 1977 Mar; 9(1):411-2. PubMed ID: 867497
    [No Abstract]   [Full Text] [Related]  

  • 39. HLA antigens in multiple sclerosis.
    Sachs JA
    Proc R Soc Med; 1977 Dec; 70(12):869-71. PubMed ID: 341175
    [No Abstract]   [Full Text] [Related]  

  • 40. The histocompatibility (HLA) antigen distribution in multiple sclerosis patients in Zimbabwe.
    Lowe RF; Moore HH; Briggs BR
    Cent Afr J Med; 1980 Nov; 26(11):234-6. PubMed ID: 7471189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.